Farklı yönleriyle NETosis

Gelişmiş ve gelişmekte olan ülkelerde otoimmün ve otoinflamatuar hastalıkların görülme sıklığında ciddi bir artış vardır. Bu hastalıkların etiyolojisi karmaşık ve multifaktöriyel nedenlere bağlı gelişmektedir. Sistemik otoimmün hastalıkların temelinde otoantijenler olduğu düşünülmektedir. Son yıllarda yapılan çalışmalar NETosisin bazı otoimmün ve otoinflamasyon hastalıkları tetikleyebileceği ortaya konulmuş ve bu savunma mekanizması büyük ilgi görmeye başlamıştır. Bu karmaşık mekanizmanın daha iyi anlaşılması otoimmün hastalıkların teşhisinde önemli araçların geliştirilmesi ile beraberinde bu hastalıklara yeni tedavi yöntemlerinin belirlenmesinde oldukça umut verici ve kritik bir öneme sahip olduğu düşünülmektedir. Bu derlemede organizmada bazı patolojilere karışan netosis hakkında bilgi verilmiştir

Different aspects of NETosis

Autoimmune and autoinflammatory diseases have dramatically increased in both developed and developing countries. The etiology of these diseases is complex and developed due to multifactorial causes. It is tought that autoantigens are the basis of systemic autoimmune diseases in organism. Recent studies have revealed that NETosis can triggered some autoimmune and autoinflammatory diseases, so this defence mechanism has begun to attract great interest. A better understanding of this complex mechanism is believed to have a promising and critical prescription for the identification of new treatment modalities for these diseases with the development of important tools in the diagnosis of autoimmune diseases. In this review, information has been given on NETosis which is participate in some pathologies in the organism

PDF

___

1. Abi Abdallah DS, Denkers EY. Neutrophils cast extracellular traps in response to protozoan parasites. Front Immunol, 2012; 3: 382.
2. Mocsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med. 2013; 210(7): 1283-99.
3. Papayannopoulos V, Zychlinsky A. NETs: a new strategy for using old weapons. Trends in Immunol, 2009; 30(11): 513-21.
4. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science, 2004; 303(5663): 1532-5.
5. Branzk N, Papayannopoulos V. Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol, 2013; 35(4): 513- 306.
6. Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biols, 2012; 198(5): 773-83.
7. TPruchniak MP, Kotula I, Manda-Handzlik A. Neutrophil extracellular traps (Nets) impact upon autoimmune disorders. Cent Eur J Immunol, 2015; 40(2): 217-24.
8. Yildiz K. Netosis: Alternative defense method used by neutrophils to fight pathogen. Acta Parasitologica Turcica, 2016; 40(3): 158-62.
9. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol, 2006; 6(3): 173-82.
10. Amagai M, Matsushima K. Overview on autoimmunity and autoinflammation. Inflamm Regen, 2011; 31(1): 50-1.
11. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med, 2006; 3(8): e297.
12. Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L, et al. Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev, 2012; 12(1): 22-30.
13. Kaufmann SH. Immunology’s foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff. Nat Immunol, 2008; 9(7): 705-12.
14. Beiter T, Fragasso A, Hartl D, Niess AM. Neutrophil extracellular traps: a walk on the wild side of exercise immunology. Sports Med, 2015; 45(5): 625-40.
15. Vorobjeva NV, Pinegin BV. Neutrophil extracellular traps: mechanisms of formation and role in health and disease. Biochemistry (Mosc), 2014; 79(12): 1286-96.
16. von Brühl M-L, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. The J Exp Med, 2012; 209(4): 819-35.
17. Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. Febs Letters, 2010; 584(14): 3193-7.
18. Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost 2011;9(9):1795-803.
19. Vogelmeier C, Döring G. Neutrophil proteinases and rhDNase therapy in cystic fibrosis. Eur Respi J, 1996; 9(11): 2193-95.
20. Ratjen F. Recent advances in cystic fibrosis. Paediatr Respi Rev, 2008; 9(2): 144-8.
21. Roghanian A, Sallenave J-M. Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease). J Aerosol Med Pulm Drug Deliv, 2008; 21(1): 125-44.
22. Papayannopoulos V, Staab D, Zychlinsky A. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy. PloS one, 2011; 6(12): e28526.
23. Hahn S, Giaglis S, Hoesli I, Hasler P. Neutrophil NETs in reproduction: from infertility to preeclampsia and the possibility of fetal loss. Front Immunol, 2012; 3: 362.
24. Salamonsen LA, Lathbury LJ. Endometrial leukocytes and menstruation. Hum Reprod Update, 2000; 6(1): 16-27.
25. Smith JM, Shen Z, Wira CR, Fanger MW, Shen L. Effects of menstrual cycle status and gender on human neutrophil phenotype. Am J Reprod Immunol, 2007; 58(2): 111-19.
26. Alghamdi AS, Lovaas BJ, Bird SL, Lamb GC, Rendahl AK, Taube PC, et al. Species-specific interaction of seminal plasma on spermneutrophil binding. Anim Reprod Sci, 2009; 114(4): 331-44.
27. Roberts JM, Redman C. Pre-eclampsia: more than pregnancy-induced hypertension. The Lancet, 1993; 341(8858): 1447-51.
28. Gupta AK, Hasler P, Holzgreve W, Gebhardt S, Hahn S. Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol, 2005; 66(11): 1146-54.
29. Gupta A, Hasler P, Gebhardt S, Holzgreve W, Hahn S. Occurrence of Neutrophil Extracellular DNA Traps (NETs) in Pre‐Eclampsia. Ann N Y Acad of Sci, 2006; 1075(1): 118-22.
30. Gupta AK, Hasler P, Holzgreve W, Hahn S. Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? In: Seminars in immunopathology; 2007: Springer, 2007: 29(2); 163-7.
31. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig, 2004; 11(6): 342-52.
32. Bergonier D, de Cremoux R, Rupp R, Lagriffoul G, Berthelot X. Mastitis of dairy small ruminants. Vet Res, 2003; 34(5): 689-716.
33. Pisanu S, Cubeddu T, Pagnozzi D, Rocca S, Cacciotto C, Alberti A, et al. Neutrophil extracellular traps in sheep mastitis. Vet Res, 2015; 46(1): 1.
34. Vitkov L, Klappacher M, Hannig M, Krautgartner W. Extracellular neutrophil traps in periodontitis. J Periodontal Res, 2009; 44(5): 664-72
5. Farquharson D, Butcher J, Culshaw S. Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal immunol, 2012; 5(2): 112-20.
36. Almyroudis NG, Grimm MJ, Davidson BA, Rohm M, Urban CF, Segal BH. NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury. Front Immunol, 2013; 4: 45.
37. Stasia MJ, Li XJ. Genetics and immunopathology of chronic granulomatous disease. In: Seminars in immunopathology; 2008: Springer, 2008; 30(3): 209-35.
38. Bianchi M, Hakkim A, Brinkmann V, Siler U, Seger RA, Zychlinsky A, et al. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood, 2009; 114(13): 2619-22.
39. Fadini GP, Menegazzo L, Rigato M, Scattolini V, Poncina N, Bruttocao A, et al. NETosis Delays Diabetic Wound Healing in Mice and Humans. Diabetes, 2016; 65(4): 1061.
40. Yang H, Biermann MH, Brauner JM, Liu Y, Zhao Y, Herrmann M. New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation. Front Immunol, 2016; 7: 302.
41. Fadini GP, Menegazzo L, Scattolini V, Gintoli M, Albiero M, Avogaro A. A perspective on NETosis in diabetes and cardiometabolic disorders. Nutr Metab Cardiovasc Dis, 2016; 26(1): 1-8.
42. Wong SL, Demers M, Martinod K, Gallant M, Wang YM, Goldfine AB, et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med, 2015; 21(7): 815.
43. Berezin A. Is the neutrophil extracellular trapdriven microvascular inflammation essential for diabetes vasculopathy? Biomed Res Ther, 2016; 3(5): 1-7.
44. Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol, 2014; 10(5): 293-302.
45. Rensen SS, Slaats Y, Nijhuis J, Jans A, Bieghs V, Driessen A, et al. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol, 2009; 175(4): 1473-82.
46. Yipp BG, Kubes P. NETosis: how vital is it? Blood, 2013; 122(16): 2784-94.
47. Dwivedi N, Radic M. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann Rheum Dis, 2014; 73(3): 483-91.
48. Hasler P, Giaglis S, Hahn S. Neutrophil extracellular traps in health and disease. Swiss Med Wkly, 2016; 146: w14352.
49. Yu Y, Su K. Neutrophil extracellular traps and systemic lupus erythematosus. J Clin Cell Immunol, 2013; 4.
50. Crispin JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, et al. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med, 2010; 16(2): 47-57.
51. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol, 2011; 187(1): 490-500.
52. Hu SC, Yu HS, Yen FL, Lin CL, Chen GS, Lan CC. Neutrophil extracellular trap formation is increased in psoriasis and induces human beta-defensin-2 production in epidermal keratinocytes. Sci Rep, 2016; 6: 31119.
53. Brandau S, Dumitru CA, Lang S. Protumor and antitumor functions of neutrophil granulocytes. In: Seminars in immunopathology; 2013: Springer, 2013; 35(2): 163-76.
54. Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res, 2011; 71(7): 2411-16.
55. Cedervall J, Zhang Y, Huang H, Zhang L, Femel J, Dimberg A, et al. Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals. Cancer Res 2015; 75(13): 2653-62.
56. Berger-Achituv S, Brinkmann V, Abed UA, Kuhn LI, Ben-Ezra J, Elhasid R, et al. A proposed role for neutrophil extracellular traps in cancer immunoediting. Front Immunol, 2013; 4: 48.
57. Swystun LL, Mukherjee S, Liaw PC. Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus. J Thrombo Haemost, 2011; 9(11): 2313-21.
58. Demers M, Wagner DD. NETosis: a new factor in tumor progression and cancer-associated thrombosis. Semin Thromb Hemost, 2014; 40(3): 277-83